NCT03177070View on ClinicalTrials.gov

Fluorescent Imaging & Methylene Blue: Ureter Study

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 9, 2016

Primary Completion Date

May 2, 2017

Study Completion Date

May 2, 2017

Conditions
Ureteric InjurySurgerySurgery--Complications
Interventions
DRUG

Methylene Blue

As described above. Intravenous injection with visualisation via fluorescence enabled laparoscope.

Trial Locations (1)

OX3 9DS

Oxford University Hospitals NHS Foundation Trust, Oxford

All Listed Sponsors
lead

University of Oxford

OTHER

NCT03177070 - Fluorescent Imaging & Methylene Blue: Ureter Study | Biotech Hunter | Biotech Hunter